UPDATE
: Monday, September 7, 2020
Home
Login
Mobile Version
All
Hospital
Pharma
Bio
Korea‘s Bio Industry
Device/ICT
Policy
People
Life science
Special
Innovation for Survival
Korea’s medical culture series
Korea’s New Candidate Drug Watch List
Special Series in Celebration of KBR's 1st Anniversary
Interview with foreign envoys
Special Series in Celebration of KBR’s 2nd Anniversary
Interview with global pharma
Special Series in Celebration of KBR’s 3rd Anniversary
Special Series in Celebration of KBR’s 4th Anniversary
ASCO 2020 Highlights
Opinion
Reporter’s Notebook
Search
트위터
페이스북
RSS
상단여백
제목보기
제목보기
제목+내용
Kolmar CEO steps down, apologizes for controversial video
Kolmar Korea CEO Yoon Dong-han, the owner of the nation’s largest manufactu...
by Lee Han-soo
|
2019-08-12 11:11
라인
Kolmar apologizes for playing controversial YouTube clip
Kolmar Korea, the nation’s largest manufacturer of cosmetic products which ...
by Lee Han-soo
|
2019-08-09 16:48
라인
Diabetes drug Jardiance pressures heart failure treatment Entresto
Novartis’ new heart failure treatment Entresto (ingredient: sacubitril/vals...
by Kim Yun-mi
|
2019-08-09 15:44
라인
AstraZeneca’s Lynparza show positive results for prostate cancer in P3 trial
AstraZeneca and MSD announced positive results from their phase 3 PROfound ...
by Lee Han-soo
|
2019-08-08 16:48
라인
‘CPhI Korea thriving on local firms’ zeal for drug export’
Korea Pharmaceutical Traders Association (KPTA) said it would open a large-...
by Jeong Sae-im
|
2019-08-08 14:54
라인
Hanmi’s US partner unveils P3 data on oral anticancer drug
Athenex, Hanmi’s U.S. partner, presented the topline data showing that Orax...
by Lee Han-soo
|
2019-08-08 14:53
라인
'Daewoong risk' could put a damper on AbbVie-Allergan mega-merger
Daewoong Pharmaceutical's launch of Jeuveau, its botulinum toxin (BTX) ...
by Lee Han-soo
|
2019-08-07 16:22
라인
Lilly’s anticancer combo drug nears getting insurance benefit
Eli Lilly said its anticancer drug Verzenio showed an improvement in overal...
by Kim Yun-mi
|
2019-08-07 15:44
라인
Lilly reports improved survival for Verzenio in P3 trial
Eli Lilly Korea said that Verzenio (Ingredient: Abemaciclib) demonstrated a...
by Lee Han-soo
|
2019-08-07 12:06
라인
ISU Abxis to unveil p1 results for anticancer treatment in Europe
ISU Abxis will present its phase 1 clinical trial data for ISU104, an Erb-B...
by Lee Han-soo
|
2019-08-07 12:03
라인
Crystal Genomics signs accord with CRO firm
Crystal Genomics said that it has signed an agreement with PRA Health Scien...
by Lee Han-soo
|
2019-08-06 17:20
라인
Japanese firms fear boycott may hurt prescription drug sales
Korean offshoots of Japanese pharmaceutical companies are worrying that the...
by Kim Yun-mi
|
2019-08-06 15:44
라인
Sillajen cites salvation therapy as reason for trial suspension advice
Sillajen said that it believes that the Independent Data Monitoring Committ...
by Lee Han-soo
|
2019-08-06 15:43
라인
Market value of biopharmaceuticals drops ₩10 trillion on 'Black Monday'
Biopharmaceutical shares in the nation’s secondary bourse had their worst d...
by Lee Han-soo
|
2019-08-06 13:50
라인
Crystal Genomics confirms efficacy of inflammatory bowel disease treatment
Crystal Genomics said that it has confirmed the efficacy of CG-598, an infl...
by Lee Han-soo
|
2019-08-05 17:02
라인
Boycott of Japanese drug intensifies as Seoul-Tokyo relations worsen
With Japan deciding to remove South Korea from the list of trusted trading ...
by Lee Han-soo
|
2019-08-05 16:01
라인
Amgen’s lipid-lowering Repatha beats Sanofi’s Praluent in Q2 sales
Amgen won the battle against Sanofi in sales of cholesterol-lowering PCSK9 ...
by Kim Yun-mi
|
2019-08-05 15:37
라인
Helixmith unveils results for neuromuscular disease treatment
Helixmith has published a study that confirmed the efficacy of AV6-H’s, a g...
by Lee Han-soo
|
2019-08-02 17:52
라인
‘MSD Korea playing tricks to maintain monitoring on salespersons’
MSD Korea’s labor and management are again in dispute over the so-called “s...
by Kim Yun-mi
|
2019-08-02 15:48
라인
Conflict erupts between employees of Takeda, Shire during merger
Takeda Pharmaceutical Korea’s labor union said Takeda employees faced unfai...
by Kim Yun-mi
|
2019-08-02 14:23
-
이전
31
32
33
34
35
36
37
38
-
176 civic groups furious over government-doctors deal
Amgen Korea wins new indication for acute lymphoblastic leukemia drug
UBcare wins patent for tech to monitor suspected infectious diseases
SCM Lifescience punished for delaying adverse reaction report
176 civic groups furious over government-doctors deal
Amgen Korea wins new indication for acute lymphoblastic leukemia drug
UBcare wins patent for tech to monitor suspected infectious diseases
SCM Lifescience punished for delaying adverse reaction report
여백
Most viewed
1
‘Cyramza helped improve gastric cancer treatment in Korea’
2
‘Reduced-dose prasugrel effective for ACS patients undergoing PCI’
3
Amgen Korea wins new indication for acute lymphoblastic leukemia drug
4
SNUBH develops AI model predicting patients at risk of cerebral aneurysm
5
Novavax releases encouraging phase-1 results on Covid-19 vaccine candidate
6
LG Chem, SK Bioscience end sales partnership with Daewoong
7
UBcare wins patent for tech to monitor suspected infectious diseases
8
176 civic groups furious over government-doctors deal
9
Recovered Covid-19 patients suffer from aftereffects – for long
10
Regulator OKs JW Pharma's rheumarthritis drug for treating giant cell arteries
여백
Opinion
[Column] Correct diagnosis leads to proper treatment
[Column] How ongoing doctors’ strike is different from 20 years ago
A Korean-American Doctor asks: Is Korea truly in 2020?
여백
Back to Top